⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INAB News
IN8bio, Inc. Common Stock
Form 8-K
sec.gov
INAB
IN8bio to Present at TD Cowen 46th Annual Health Care Conference
globenewswire.com
INAB
IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer
globenewswire.com
INAB
IN8bio to Present at Upcoming Investor and Scientific Conferences in February
globenewswire.com
INAB
IN8bio Presents Updated Phase I/II Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma
globenewswire.com
INAB
IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager
globenewswire.com
INAB
IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights
globenewswire.com
INAB
IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site
globenewswire.com
INAB
IN8bio Presents T cell Engager Data Demonstrating Deep B Cell Depletion for Autoimmune Indications
globenewswire.com
INAB